arrow
返回
L

Li‐Tzong Chen

national cheng kung university hospital

55H指数
538论文数
1.7W被引数
收录论文 176
发表时间
SLOG versus Modified FOLFIRINOX as First-Line Treatment for Advanced Pancreatic Cancer: A Randomized Phase II Trial (TCOG T5217)SLOG与改良FOLFIRINOX作为晚期胰腺癌一线治疗的比较:一项随机II期临床试验(TCOG T5217)
err2026-01-11
err0
PREAI
errNai-Jung Chiang; Yung-Yeh Su; I-Wei Ho; Li-Yuan Bai; Chung-Pin Li; Jen-Shi Chen; Chin-Fu Hsiao; Hsiao-Hui Tsou; Chiun Hsu; Tai-Jan Chiu; Yao-Yu Hsieh; Kun-Ming Rau; Ching-Liang Ho; Yan-Shen Shan; Li-Tzong Chen
err分享
err收藏
Second-line 5-FU plus nanoliposomal irinotecan versus FOLFOX/XELOX in metastatic pancreatic cancer after gemcitabine–nab-paclitaxel failure: a propensity score-matched analysis二线5-FU联合纳米脂质体伊立替康与FOLFOX/XELOX方案对比:在吉西他滨–白蛋白结合型紫杉醇治疗失败后的转移性胰腺癌中的倾向性评分匹配分析
err2025-11-07
err0
errOAAI
errG. Trovato; D. Rossini; A. Guidolin; Y.-Y. Su; Y.-S. Shan; N.-J. Chiang; W.-C. Chou; L.-Y. Bai; C. Bagalà; M. Bensi; M. Niger; S. Marchesi; S.K. Garattini; A. Michelotti; A. Pretta; M. Scartozzi; C. Vivaldi; L. Bartalini; L. Procaccio; F. Bergamo; L. Antonuzzo; L.-T. Chen; L. Salvatore; G. Tortora
err分享
err收藏
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with pancreatic cancer泛亚洲适应性ESMO临床实践指南:胰腺癌患者的诊断、治疗和随访
err2025-10-09
err0
errOAAI
errD. Tai; T. Conroy; J.J.X. Lee; C.E. Chee; C.-Y. Hao; I. Wijaya; S. Aggarwal; M. Ueno; H.-C. Jeung; N.M. Hashim; J. Tan Chun Bing; L.-T. Chen; K. Korphaisarn; S. Tanasanvimon; W.-C. Chou; E. Cargullo; N.F.A. Muin; M.A. Lee; A. Ohba; S. Bondarde; C.R.A. Lesmana; L. Wang; E.C. Smyth; T. Yoshino; G. Bonney; G. Pentheroudakis; J. Samol; A. Cervantes; E. Poon; M. Ducreux
err分享
err收藏
Taiwan liver cancer association management consensus guidelines for intermediate-stage hepatocellular carcinoma台湾肝癌协会关于中晚期肝细胞癌的管理共识指南
err2025-10-01
err1
errOAAI
errLee, I-Cheng; Wang, Hung-Wei; Teng, Wei; Lin, Tsung-Jung; Chen, Chien-Hung; Lai, Hsueh-Chou; Lee, Teng-Yu; Chang, Ching-Wei; Hung, Chao-Hung; Dai, Chia-Yen; Hung, Yi-Ping; Shen, Ying-Chun; Su, Chien-Wei; Ho, Ming-Chih; Lee, Wei-Chen; Chau, Gar-Yang; Ting, Chin-Tsung; Liang, Po-Chin; Liu, Chien-An; Chang, Pi-Yi; Chen, Kuan-Yang; Lin, Shi-Ming; Chen, Li-Tzong; Huang, Yi-Hsiang
err分享
err收藏
Clinical outcomes of gastroenteropancreatic neuroendocrine neoplasms in Taiwan: A multicenter registry study—TCOG T1214 study台湾地区胃肠胰神经内分泌新生物的临床结局:一项多中心登记研究—TCOG T1214研究
errCancer
IF5.1
err2025-08-20
err0
errOAAI
errHui-Jen Tsai MD PhD; Ming-Huang Chen MD PhD; Hsiu-Po Wang MD; Chin-Fu Hsiao PhD; Yen-Yang Chen MD PhD; Jen-Shi Chen MD; Mei-Due Yang MD PhD; Chin-Yuan Tzen MD PhD; Yan-Shen Shan MD PhD; Li-Yaun Bai MD PhD; De-Chuan Chan MD; Pei-Yi Chu MD PhD; Ching-Liang Ho MD; Youngsen Yang MD; Johnson Lin MD; Hsuan-Yu Lin MD; Cheng-Shyong Chang MD; Chuan-Cheng Wang MD; Tsann-Long Hwang MD; Li-Tzong Chen MD PhD
err分享
err收藏
Durvalumab plus chemotherapy in advanced biliary tract cancer: 3-year overall survival update from the phase III TOPAZ-1 study度伐鲁单抗联合化疗在晚期胆道癌中的应用:III期TOPAZ-1研究的3年总生存期更新
err2025-05-15
err0
errOAAI
errDo-Youn Oh; Aiwu Ruth He; Shukui Qin; Li-Tzong Chen; Takuji Okusaka; Jin Won Kim; Thatthan Suksombooncharoen; Myung Ah Lee; Masayuki Kitano; Howard A. Burris; Mohamed Bouattour; Suebpong Tanasanvimon; Renata Zaucha; Antonio Avallone; Juan Cundom; Aleksandra Kuzko; Julie Wang; Ioannis Xynos; Arndt Vogel; Juan W. Valle
err分享
err收藏
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with biliary tract cancer (vol 9, 103647, 2024)
err2025-01-01
err0
errOAAI
errChen, L. -T.; Vogel, A.; Hsu, C.; Chen, M. -H.; Fang, W.; Pangarsa, E. A.; Sharma, A.; Ikeda, M.; Park, J. O.; Tan, C. K.; Regala, E.; Tai, D.; Tanasanvimon, S.; Charoentum, C.; Chee, C. E.; Lui, A.; Sow, J.; Oh, D. -Y.; Ueno, M.; Ramaswamy, A.; Jeo, W. S.; Zhou, J.; Curigliano, G.; Yoshino, T.; Bai, L. -Y.; Pentheroudakis, G.; Chiang, N. -J.; Cervantes, A.; Chen, J. -S.; Ducreux, M.
err分享
err收藏
Nivolumab plus chemotherapy in patients with HER2-negative, previously untreated, unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer: 3-year follow-up of the ATTRACTION-4 randomized, double-blind, placebo-controlled, phase 3 trialNivolumab联合化疗治疗HER2-negative,既往未治疗,不可切除,晚期或复发性胃/胃食管交界癌患者: 吸引-4随机,双盲,安慰剂对照,3期临床试验的3年随访
err2024-08-20
err1
errOAAI
errBoku, Narikazu; Omori, Takeshi; Shitara, Kohei; Sakuramoto, Shinichi; Yamaguchi, Kensei; Kato, Ken; Kadowaki, Shigenori; Tsuji, Kunihiro; Ryu, Min-Hee; Oh, Do-Youn; Oh, Sang Cheul; Rha, Sun Young; Lee, Keun-Wook; Chung, Ik-Joo; Sym, Sun Jin; Chen, Li-Tzong; Chen, Jen-Shi; Bai, Li-Yuan; Nakada, Takashi; Hagihara, Shunsuke; Makino, Reina; Nishiyama, Eiji; Kang, Yoon-Koo
err分享
err收藏
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with biliary tract cancer泛亚适应ESMO临床实践指南,用于胆道癌患者的诊断,治疗和随访
err2024-08-01
err0
errOAAI
errChen, L. -T; Vogel, A.; Hsu, C.; Chen, M. -h.; Fang, W.; Pangarsa, E. A.; Sharma, A.; Ikeda, M.; Park, J. O.; Tan, C. K.; Regala, E.; Tai, D.; Tanasanvimon, S.; Charoentum, C.; Chee, C. E.; Lui, A.; Sow, J.; Oh, D. -y.; Ueno, M.; Ramaswamy, A.; Jeo, W. S.; Zhou, J.; Curigliano, G.; Yoshino, T.; Bai, L. -y.; Pentheroudakis, G.; Chiang, N. -j.; Cervantes, A.; Chen, J. -s.; Ducreux, M.
err分享
err收藏
Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1) : updated overall survival from a randomised phase 3 study
err2024-08-01
err15
PREAI
errOh, Do-Youn; He, Aiwu Ruth; Bouattour, Mohamed; Okusaka, Takuji; Qin, Shukui; Chen, Li-Tzong; Kitano, Masayuki; Lee, Choong-kun; Kim, Jin Won; Chen, Ming -Huang; Suksombooncharoen, Thatthan; Ikeda, Masafumi; Lee, Myung Ah; Chen, Jen-Shi; Potemski, Piotr; Burris, Howard A.; Ostwal, Vikas; Tanasanvimon, Suebpong; Morizane, Chigusa; Zaucha, Renata E.; Mcnamara, Mairead G.; Avallone, Antonio; Cundom, Juan E.; Breder, Valeriy; Tan, Benjamin; Shimizu, Satoshi; Tougeron, David; Evesque, Ludovic; Petrova, Mila; Zhen, David B.; Gillmore, Roopinder; Gupta, Vineet Govinda; Dayyani, Farshid; Park, Joon Oh; Buchschacher Jr, Gary L.; Rey, Felipe; Kim, Hyosung; Wang, Julie; Morgan, Claire; Rokutanda, Nana; Zotkiewicz, Magdalena; Vogel, Arndt; Valle, Juan W.
err分享
err收藏
Survival of advanced/recurrent gastrointestinal stromal tumors treated with tyrosine kinase inhibitors in Taiwan: a nationwide registry study
err2024-07-11
err0
errOAAI
errTsai, Hui-Jen; Shan, Yan-Shen; Yang, Ching-Yao; Hsiao, Chin-Fu; Tsai, Chung-Hsin; Wang, Chuan-Cheng; Lin, Ming-Tsan; Ting, Chun-Fu; Chan, De-Chuan; Chen, Te-Hung; Yen, Chueh-Chuan; Chen, Yen-Yang; Lin, Hsuan-Yu; Yeh, Ta-Sen; Ho, Ching-Liang; Shieh, Tze-Yu; Bai, Li-Yaun; Hsu, Jun-Te; Chen, I-Shu; Chen, Li-Tzong; Yeh, Chun-Nan; Liu, Tsang-Wu; Chuang, Chieh-Han; Wang, Tsang-En
err分享
err收藏
Plain language summary of the FOENIX-CCA2 study: futibatinib for people with advanced bile duct cancerFOENIX-CCA2研究的简明语言摘要: futibatinib用于晚期胆管癌患者
err2024-06-17
err0
errOAAI
errGoyal, Lipika; Meric-Bernstam, Funda; Hollebecque, Antoine; Valle, Juan W.; Morizane, Chigusa; Karasic, Thomas B.; Abrams, Thomas A.; Furuse, Junji; Kelley, Robin Katie; Cassier, Philippe A.; Klumpen, Heinz-Josef; Chang, Heung-Moon; Chen, Li-Tzong; Tabernero, Josep; Oh, Do-Youn; Mahipal, Amit; Moehler, Markus; Komatsu, Yoshito; Ahn, Daniel H.; Epstein, Robert S.; Halim, Abdel-Baset; Wacheck, Volker; He, Yaohua; Liu, Mei; Benhadji, Karim A.; Bridgewater, John A.
err分享
err收藏
First-in-human phase 1 study of a phosphatidylserine-targeting small molecule drug conjugate (T-1201) in patients with advanced solid tumors
err2024-04-05
err0
PREAI
errWang, Hui-Ching; Yeh, Yu-Min; Du, Jeng-Shiun; Yeh, Tsung-Jang; Tsai, Jui-Hung; Gau, Yu-Chin; Wu, Shang Yin; Chen, Li-Tzong; Li, Hsiao-Fang; Su, Wu-Chou
err分享
err收藏
Trial in progress: Phase 1 dose escalation study of T-1101, a first-in-class oral Hec1/Nek2 inhibitor, in patients with advanced refractory solid tumors
err2024-04-05
err0
PREAI
errSu, Wu-Chou; Bai, Li-Yuan; Hsiao, Hui-Hua; Shiah, Her-Shyong; Yeh, Yu-Min; Chen, Shang-Hung; Wu, Shang-Yin; Wang, Hui-Ching; Tsai, Hui-Jen; Chang, Kwang-Yu; Tsai, Jui-Hung; Lee, Chun-Hui; Lee, Chieh Hua; Chao, Yu-Sheng; Chen, Li-Tzong
err分享
err收藏
A phase 1 multi-center, open label, dose escalation study to evaluate the safety, pharmacokinetics (PK) and anti-tumor activity of T-1301, a novel small molecular
err2024-04-05
err0
PREAI
errChen, Jen-Shi; Chen, Ming-Huang; Liu, Yi-Chang; Chou, Wen-Chi; Chiang, Nai-Jung; Wang, Hui-Ching; Yeh, Ta-Sen; Cho, Shih-Feng; Wang, Cheng-Hsu; Lee, I-Fang; Chen, Li-Tzong
err分享
err收藏
Germline mutations of homologous recombination genes and clinical outcomes in pancreatic cancer: a multicenter study in Taiwan胰腺癌同源重组基因的种系突变和临床结果: 台湾的多中心研究
err2024-02-13
err4
errOAAI
errCheng, Siao Muk; Su, Yung-Yeh; Chiang, Nai-Jung; Wang, Chih-Jung; Chao, Ying-Jui; Huang, Chien-Jui; Tsai, Hui-Jen; Chen, Shang-Hung; Chang, Chi-Yen; Tsai, Chia-Rung; Li, Yi-Jie; Yen, Chia-Jui; Chuang, Shih-Chang; Chang, Jeffrey Shu-Ming; Shan, Yan-Shen; Hwang, Daw-Yang; Chen, Li-Tzong
err分享
err收藏
Outcomes of Post-Immunotherapy Durable Responders of Advanced Hepatocellular Carcinoma- with Emphasis on Locoregional Therapy for Oligoprogression晚期肝细胞癌的免疫治疗后持久反应的结果-强调局部区域治疗的寡进展
err2024-02-01
err0
errOAAI
errLiu, Tsung-Hao; Chen, San-Chi; Rau, Kun-Ming; Lu, Li-Chun; Lin, Po-Ting; Su, Yung-Yeh; Teng, Wei; Lai, Shiue-Wei; Yeh, Ren-Hua; Kao, Tsui-Mai; Lee, Pei-Chang; Wu, Chi-Jung; Chen, Chien-Hung; Hsu, Chih-Hung; Lin, Shi-Ming; Huang, Yi-Hsiang; Chen, Li-Tzong; Cheng, Ann-Lii; Shen, Ying-Chun
err分享
err收藏